Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Greenwich LifeSciences (GLSI) has a market cap of $0.12 billion USD. According to our data, Greenwich LifeSciences is ranked No.7440 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $0.12 B |
-19.52%
|
| Dec 31, 2024 | $0.15 B |
6.75%
|
| Dec 29, 2023 | $0.14 B |
-30.79%
|
| Dec 30, 2022 | $0.20 B |
-37.53%
|
| Dec 31, 2021 | $0.32 B |
-33.29%
|
| Dec 31, 2020 | $0.48 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sutro Biopharma
STRO
|
$43.95 M |
0.385 M
|
USA
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Genmab
GMAB
|
$12.54 B |
-0.000 M
|
Denmark
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
| Market Cap | = | GLSI Stock Price | * | GLSI Shares Outstanding |
| = | $8.95 | * | 13.27 M | |
| = | $0.12 B |